Headshot photo of Tomasz M. Beer, M.D., FACP

Tomasz M. Beer, M.D., FACP


Dr. Tomasz (Tom) Beer cares for men with prostate cancer at OHSU and at the Portland VA Medical Center.

Dr. Beer was formerly a professor of medicine and Grover C. Bagby Endowed Chair for Prostate Cancer Research in the Division of Hematology and Medical Oncology, where he led the Prostate Cancer Research Program, encompassing basic research, translational research, clinical trials of novel therapeutic strategies in prostate cancer, and studies aimed at enhancing cancer survivorship. He has authored or co-authored more than 250 peer-reviewed articles on prostate cancer. Dr. Beer is particularly known for investigations of targeted therapies and immunotherapies in prostate cancer, including vitamin D receptor, the androgen receptor, CTLA-4 and PD-1 inhibitors, PSMA and others. He led the global randomized trial of enzalutamide vs placebo which demonstrated substantial improvements in overall and progression-free survival as well as quality of life and served as the basis for a global change in the standard of care for advanced prostate cancer. 

Dr. Beer served as Deputy Director of the OHSU Knight Cancer institute and as Chief Medical Officer for the Center for Early Detection Advanced Research (CEDAR).

Education and training

  • Degrees

    • M.D., 1991, The Johns Hopkins University
  • Residency

    • Oregon Health & Science University, Portland
  • Fellowship

    • Hematology and Medical oncology, Oregon Health & Science University, Portland
  • Certifications

    • Oncology

Memberships and associations:

  • American College of Physicians
  • Oregon Medical Association
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • Southwest Oncology Group
  • American Urological Association


Elsevier pure profile


  • {{ pub.journalAssociation.journal.name.text[0].value }}